CIK 0000920148 · Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 992588107
- Phone
- 3362291127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,195,768
- in 4 filings, $1.1M under 10b5-1 plans
Net −$2,195,768. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-02 | Kyle Kathryn W EVP, Chief Legal Officer | Sale 10b5-1 | −92 | $286.19 | $26K | 3,904.46 |
| 2026-07-02 | Vaughn Bryan T EVP and President, Diagnostics | Sale 10b5-1 | −234 | $286.19 | $67K | 6,745.57 |
| 2026-07-01 | Kyle Kathryn W EVP, Chief Legal Officer | Option exercise 10b5-1 | +256 | 4,069.46 | ||
| 2026-07-01 | Kyle Kathryn W EVP, Chief Legal Officer | Shares withheld for taxes 10b5-1 | −73 | $283.88 | $21K | 3,996.46 |
| 2026-07-01 | Kyle Kathryn W EVP, Chief Legal Officer | Option exercise · Restricted Stock Unit 10b5-1 | −256 | 2,008 | ||
| 2026-07-01 | Vaughn Bryan T EVP and President, Diagnostics | Option exercise 10b5-1 | +327 | 7,072.57 | ||
| 2026-07-01 | Vaughn Bryan T EVP and President, Diagnostics | Shares withheld for taxes 10b5-1 | −93 | $283.88 | $26K | 6,979.57 |
| 2026-07-01 | Vaughn Bryan T EVP and President, Diagnostics | Option exercise · Restricted Stock Unit 10b5-1 | −327 | 3,704 | ||
| 2026-06-08 | Kyle Kathryn W EVP, Chief Legal Officer | Sale 10b5-1 | −762 | $263.89 | $201K | 3,813.46 |
| 2026-05-11 | Schechter Adam H President & CEO | Sale 10b5-1 | −5,903 | $254.50 | $1.5M | 107,234 |
| 2026-03-27 | Wilkinson Peter J SVP, Chief Accounting Officer | Sale 10b5-1 | −1,633 | $267.05 | $436K | 1,852.22 |
| 2026-03-27 | Meltzer Jonathan C EVP, Operations | Sale 10b5-1 | −839 | $267.05 | $224K | 3,620.33 |
| 2026-03-26 | Schechter Adam H President & CEO | Grant or award | +58,470 | 139,243 | ||
| 2026-03-26 | Schechter Adam H President & CEO | Shares withheld for taxes | −26,106 | $268.38 | $7.0M | 113,137 |
| 2026-03-26 | GRAHAM ANITA Z EVP, CHRO | Grant or award | +6,604 | 8,064 | ||
| 2026-03-26 | GRAHAM ANITA Z EVP, CHRO | Shares withheld for taxes | −2,879 | $268.38 | $773K | 5,185 |
| 2026-03-26 | Schroeder Mark S EVP, Pres Diagnostics & COO | Grant or award | +9,304 | 15,777.14 | ||
| 2026-03-26 | Schroeder Mark S EVP, Pres Diagnostics & COO | Shares withheld for taxes | −4,600 | $268.38 | $1.2M | 11,177.14 |
| 2026-03-26 | Schroeder Mark S EVP, Pres Diagnostics & COO | Grant or award | +2,968 | 14,145.14 | ||
| 2026-03-26 | Schroeder Mark S EVP, Pres Diagnostics & COO | Shares withheld for taxes | −1,468 | $268.38 | $394K | 12,677.14 |
Page 2 of 14 · 262 trades